Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Apr 22, 2015 8:49am
74 Views
Post# 23651763

RE:RE:RE:RE:RE:RE:issue with laser

RE:RE:RE:RE:RE:RE:issue with laser
LAZERR00 wrote:
made2last wrote:

Medical Reimbursement

Cold laser therapy is usually paid for in cash at clinics, as it has limited CPT code coverage. Currently, other pre-existing codes are in use for reimbursement purposes depending upon the state legislation and insurance plans. The CPT code 4 (97026) (application of a modality; infrared), has been used in the past since the laser emits light in the infrared spectrum. In January 2004, a HCPCS level 2 code (S8948) was added that is specific to cold laser therapy.

Theralase expects to secure a new CPT code for reimbursement for laser treatments in the U.S. for its new patented TLC-2000 technology. Under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), CPT codes are updated annually and effective for use on January 1 of each year. The American Medical Association prepares an annual update so that the new CPT books are available in the fall of each year, preceding their effective date to allow for implementation. With the implementation of the Patient Protection and Affordable Care Act (PPACA), the device could make even more headway in the mainstream healthcare system with over 8 million Americans expected to be added to the medical insurance system.             

https://seekingalpha.com/article/2206433-initiation-report-for-theralase-technologies



Doesn't matter if you get a CPT code or not, it only matters to clinicians if it is reimbursable.  Which it isnt



CPT codes are describers. It's a system created and maintained by the AMA and used by i.e. Medicaid which also establishes fee guidlines which is what most insurance companies use for reimbursement handlings. YES, CPT's are for identification and classification first and foremost but get CPT codes specifically for LLLT or varying treatments using LLLT and you open doors to wider acceptance as the medical community and insurance carriers get with the program. You cannot categorically say that no carriers cover LLLT under varying existing CPT codes, because some do. Fact. You cannot deny that insurers cover under 97039, because they have. Fact. It's entirely possible that 5 years from now, LLLT treatments become mainstream rather than only available to professional athletes or those that can afford it.
Since you joined yesterday with a username seemingly specific to this stock... I'm guessing you are here to try scaring retail out of a hew hundred thousands shares or whatever you can get your hands on?  If not, if you have expertise in the area, try offering us some discussion instead of closed minded denial of LLLT possibilities. If you are so completely unconvinced about the treatment and technology, why are you here?
Bullboard Posts